The 1200 Patients Project: Creating a New Medical Model System for Clinical Implementation of PharmacogenomicsO'DONNELL, P. H; BUSH, A; SPITZ, J et al.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 4, pp 446-449, issn 0009-9236, 4 p.Article

Polymorphisms in Endothelial Nitric Oxide Synthase (eNOS) and Vascular Endothelial Growth Factor (VEGF) Predict Sunitinib-Induced HypertensionEECHOUTE, K; VAN DER VELDT, A. A. M; MATHIJSSEN, R. H. J et al.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 4, pp 503-510, issn 0009-9236, 8 p.Article

Interpreting Pharmacogenetic Data in the Developing Neonate:The Challenge of Hitting a Moving TargetLEEDER, J. S; KEARNS, G. L.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 4, pp 434-436, issn 0009-9236, 3 p.Article

Strategies for Personalized Medicine-Based Research and Implementation in the Clinical WorkflowLIEB, W; VÖLZKE, H; PULLEY, J. M et al.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 4, pp 443-445, issn 0009-9236, 3 p.Article

The Relevance of Missing Heritability in PharmacogenomicsSADEE, W.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 4, pp 428-430, issn 0009-9236, 3 p.Article

Clinical Translation of Cell-Based Pharmacogenomic DiscoveryCOX, N. J; GAMAZON, E. R; WHEELER, H. E et al.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 4, pp 425-427, issn 0009-9236, 3 p.Article

Individualization of Drug Therapy: History, Present State, and Opportunities for the FutureLESKO, L. J; SCHMIDT, S.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 4, pp 458-466, issn 0009-9236, 9 p.Article

Advancing the Science of Medicines Regulation: The Role of the 21 st-Century Medicines RegulatorLUMPKIN, M. M; EICHLER, H.-G; BRECKENRIDGE, A et al.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 4, pp 486-493, issn 0009-9236, 8 p.Article

Influence of Environmental and Genetic Factors on CYP1 A2 Activity in Individuals of South Asian and European AncestryPERERA, V; GROSS, A. S; MCLACHLAN, A. J et al.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 4, pp 511-519, issn 0009-9236, 9 p.Article

The influence of renal function on the pharmacokinetics and pharmacodynamics and simulated time course of doxacuriumFISHER, D. M; REYNOLDS, K. S; SCHMITH, V. D et al.Anesthesia and analgesia. 1999, Vol 89, Num 3, pp 786-795, issn 0003-2999Article

Implementing Personalized Medicine: Development of a Cost-Effective Customized Pharmacogenetics Genotyping ArrayJOHNSON, J. A; BURKLEY, B. M; LANGAEE, T. Y et al.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 4, pp 437-439, issn 0009-9236, 3 p.Article

The Effect of Safinamide, a Novel Drug for Parkinson's Disease, on Pressor Response to Oral Tyramine: A Randomized, Double-Blind, Clinical TrialMARQUET, A; KUPAS, K; JOHNE, A et al.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 4, pp 450-457, issn 0009-9236, 8 p.Article

Personalizing Antiplatelet Therapy With ClopidogrelTRENK, D; ZOLK, O; FROMM, M. F et al.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 4, pp 476-485, issn 0009-9236, 10 p.Article

Effect of pancreatico-biliary secretions and GI transit time on the absorption and pharmacokinetic profile of ranitidine in humansREYNOLDS, K. S; SONG, M. H; HEIZER, W. D et al.Pharmaceutical research. 1998, Vol 15, Num 8, pp 1281-1285, issn 0724-8741Article

Psychological characteristics and development of narcotic-addicted infantsSTRAUSS, M. E; REYNOLDS, K. S.Drug and alcohol dependence. 1983, Vol 12, Num 4, pp 381-393, issn 0376-8716Article

Evaluation of Various Static In Vitro-In Vivo Extrapolation Models for Risk Assessment of the CYP3A Inhibition Potential of an Investigational DrugVIEIRA, Md L. T; KIRBY, B; HALL, S. D et al.Clinical pharmacology and therapeutics. 2014, Vol 95, Num 2, pp 189-198, issn 0009-9236, 10 p.Article

Population Imaging as Valuable Tool for Personalized MedicineVÖLZKE, H; SCHMIDT, C. O; HEGENSCHEID, K et al.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 4, pp 422-424, issn 0009-9236, 3 p.Article

Pharmacogenomics and Individualized Medicine:Translating Science Into PracticeCREWS, K. R; HICKS, J. K; PUI, C.-H et al.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 4, pp 467-475, issn 0009-9236, 9 p.Article

Pharmacokinetic and Pharmacodynamic Analysis of Efavirenz Dose Reduction Using an In Vitro―In Vivo Extrapolation ModelSICCARDI, M; ALMOND, L; SCHIPANI, A et al.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 4, pp 494-502, issn 0009-9236, 9 p.Article

Predicting Drug Interaction Potential With a Physiologically Based Pharmacokinetic Model: A Case Study of Telithromycin, a Time-Dependent CYP3A InhibitorVIEIRA, Mdlt; ZHAO, P; BERGLUND, E. G et al.Clinical pharmacology and therapeutics. 2012, Vol 91, Num 4, pp 700-708, issn 0009-9236, 9 p.Article

Individualization ofTamoxifen Treatment for Breast CarcinomaBINKHORST, L; VAN GELDER, T; MATHIJSSEN, R. H. J et al.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 4, pp 431-433, issn 0009-9236, 3 p.Article

Progress Toward Personalized Treatment of Rheumatoid ArthritisKEITH, M. P; EDISON, J. D; GILLILAND, W. R et al.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 4, pp 440-442, issn 0009-9236, 3 p.Article

Semi-mechanistic Population Pharmacokinetic Model of MultivalentTrastuzumab Emtansine in Patients with Metastatic Breast CancerCHUDASAMA, V. L; SCHAEDELI STARK, F; HARROLD, J. M et al.Clinical pharmacology and therapeutics. 2012, Vol 92, Num 4, pp 520-527, issn 0009-9236, 8 p.Article

Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory ReviewZHAO, P; ZHANG, L; BOOTH, B. P et al.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 2, pp 259-267, issn 0009-9236, 9 p.Article

Page / 2